arrow
T

Tomasz Gąsior

institut national de la santé et de la recherche médicale (inserm)
H指数:15
被引数:1,137

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI

心力衰竭伴或不伴糖尿病和慢性肾脏病的患者接受心肌梗死后 empa gliflozin 治疗的疗效:来自 EMPACT-MI 的启示

2025-09-140
OAAI
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial

比较研究者报告与中心裁定心力衰竭结局的EMPEROR-Preserved试验

2025-01-011
PRE
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial

依格列净对急性心肌梗死后心力衰竭预后的影响: 来自empact-mi试验的见解

2024-05-2114
OAAI
Empagliflozin after Acute Myocardial Infarction

急性心肌梗死后的依格列净

2024-04-2567
PRE
Impact of Enterococci vs. Staphylococci Induced Infective Endocarditis after Transcatheter Aortic Valve Implantation

经导管主动脉瓣植入术后肠球菌与葡萄球菌引起的感染性心内膜炎的影响

2023-02-242
OAAI
Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
2022-11-0410
OA
Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
2022-01-0117
OAAI
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement
2021-12-1124
OA